Malignancy is a hereditary sickness brought about by amassing of DNA changes and epigenetic adjustments prompting excessive cell multiplication and neoplasm arrangement. The objective of oncogenomics is to distinguish new oncogenes or tumor silencer qualities that may give new bits of knowledge into malignancy conclusion, anticipating clinical result of diseases and The achievement of focused malignancy treatments, for example, Gleevec, Herceptin and Avastin raised the desire for oncogenomics to explain new focuses for disease treatment. The worldwide disease diagnostics market size was esteemed at USD 144. 4 billion of every 2018 and is relied upon to enroll a CAGR of 7.0% over the estimate time frame.
ALSO READ Oncology Pancreatic Cancer Breast Cancer Oral and Oropharyngeal Cancer Eye Cancer Uterine Cancer Lung Cancer Skin Cancer Kidney Cancer Bladder Cancer Prostate Cancer Colorectal Cancer Anal Cancer Cervical Cancer Bone Cancer Liver Cancer Stomach Cancer Blood Cancer Brain Cancer Gastrointestinal Cancer Ovarian and Testicular Cancer Cardio-Oncology Biochemistry of Cancer Cancer Biomarkers Cancer and HIV Cancer Research and Cancer Vaccines Cancer Genetics Cancer Trends and Opportunities Nanotechnology Nanomedicine in Cancer Treatment Radiology and Imaging in Cancer Artificial Intelligence AI and its Scope in Cancer Therapy Treatment of Cancer Nutrition and Oncology
Geriatric Oncology Conferences Head & Neck Cancer Conferences Cancer Science Conferences 2020 Veterinary Oncology Conferences Oncologists Conferences Medical Oncology Conferences Oncologists Conferences 2020 Asia Cancer Science Conferences 2020 Middle-East Liver Cancer Conferences Endometrial Cancer Conferences Oncology Conferences 2020 USA Biomarkers Conferences Oncologists Conferences 2020 Europe Cytopathology Conferences Medical Imaging Conferences